These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30897527)

  • 1. Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.
    Finn MT; Redfors B; Karmpaliotis D; Kirtane AJ; Green P; McAndrew T; Liu M; Cloney MB; Witzenbichler B; Weisz G; Stuckey TD; Brodie BR; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Stone GW
    Am Heart J; 2019 May; 211():68-76. PubMed ID: 30897527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study.
    Redfors B; Généreux P; Witzenbichler B; Maehara A; Weisz G; McAndrew T; Mehran R; Kirtane AJ; Stone GW
    Am Heart J; 2018 Mar; 197():142-149. PubMed ID: 29447774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Coronary Intervention of Saphenous Vein Graft.
    Redfors B; Généreux P; Witzenbichler B; McAndrew T; Diamond J; Huang X; Maehara A; Weisz G; Mehran R; Kirtane AJ; Stone GW
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
    Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention of bifurcation lesions and platelet reactivity.
    Redfors B; Généreux P; Witzenbichler B; Kirtane AJ; Maehara A; Weisz G; Madhavan MV; McAndrew T; Mehran R; Stone GW
    Int J Cardiol; 2018 Jan; 250():92-97. PubMed ID: 29074039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
    Kirtane AJ; Parikh PB; Stuckey TD; Xu K; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Parvataneni R; Maehara A; Généreux P; Mehran R; Stone GW
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1978-1987. PubMed ID: 26738669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy.
    Rubin GA; Kirtane AJ; Chen S; Redfors B; Weisz G; Baber U; Zhang Y; Stuckey TD; Witzenbichler B; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Mehran R; Ali ZA; Ben-Yehuda O; Stone GW
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):793-801. PubMed ID: 31721430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study).
    Redfors B; Chen S; Ben-Yehuda O; Huang X; Witzenbichler B; Weisz G; Liu Y; Brodie BR; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Stuckey TD; Kirtane AJ; Stone GW
    Am J Cardiol; 2019 Nov; 124(9):1380-1388. PubMed ID: 31477234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation.
    Généreux P; Giustino G; Redfors B; Palmerini T; Witzenbichler B; Weisz G; Stuckey TD; Maehara A; Mehran R; Kirtane AJ; Stone GW
    Int J Cardiol; 2018 Oct; 268():61-67. PubMed ID: 30041804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study.
    Giustino G; Redfors B; Kirtane AJ; Mehran R; Dangas GD; Witzenbichler B; Neumann FJ; Weisz G; Généreux P; Maehara A; McAndrew T; Farhan S; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Gurbel P; Ben-Yehuda O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1277-1286. PubMed ID: 29908967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions).
    Kandzari DE; Kini AS; Karmpaliotis D; Moses JW; Tummala PE; Grantham JA; Orr C; Lombardi W; Nicholson WJ; Lembo NJ; Popma JJ; Wang J; Larracas C; Rutledge DR
    JACC Cardiovasc Interv; 2015 May; 8(6):761-769. PubMed ID: 25912400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
    Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry.
    Baber U; Mehran R; Kirtane AJ; Gurbel PA; Christodoulidis G; Maehara A; Witzenbichler B; Weisz G; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Xu K; Parise H; Brodie BR; Stuckey TD; Stone GW
    Circ Cardiovasc Interv; 2015 Jun; 8(6):e001683. PubMed ID: 26056248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.
    Giustino G; Kirtane AJ; Baber U; Généreux P; Witzenbichler B; Neumann FJ; Weisz G; Maehara A; Rinaldi MJ; Metzger C; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Gurbel PA; Dangas GD; Francese DP; Ozan O; Mehran R; Stone GW
    Am J Cardiol; 2016 Jun; 117(12):1877-83. PubMed ID: 27131611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES.
    Shahim B; Redfors B; Stuckey TD; Liu M; Zhou Z; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Srdanovic I; Madhavan MV; Mazzaferri EL; Mehran R; Ben-Yehuda O; Kirtane AJ; Stone GW
    J Am Heart Assoc; 2023 Jan; 12(1):e026482. PubMed ID: 36565189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major adverse cardiovascular events after drug-eluting stent implantation in patients with single chronic total occlusion: a single-center registry.
    Gilis-Siek N; Fijalkowski M; Jaguszewski M; Targonski R; Strozyk A; Cackowska M; Masiewicz E; Skarzynski P; Burakowski S; Chmielecki M; Lewicki L; Dubaniewicz W; Gruchala M; Ciecwierz D; Rynkiewicz A
    J Invasive Cardiol; 2013 Nov; 25(11):567-72. PubMed ID: 24184890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Midterm Prognostic Implications of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents in East Asian Patients: Results From the PTRG-DES (Platelet Function and Genotype-Related Long-Term Prognosis in Drug-Eluting Stent-Treated Patients With Coronary Artery Disease) Consortium.
    Kim SJ; Her AY; Jeong YH; Kim BK; Joo HJ; Park Y; Chang K; Song YB; Ahn SG; Suh JW; Lee SY; Cho JR; Kim HS; Kim MH; Lim DS; Shin ES;
    J Am Heart Assoc; 2023 May; 12(9):e027804. PubMed ID: 37119080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study).
    Schoos MM; Dangas GD; Mehran R; Kirtane AJ; Yu J; Litherland C; Clemmensen P; Stuckey TD; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Maehara A; Stone GW
    Am J Cardiol; 2016 Jan; 117(2):192-200. PubMed ID: 26639039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy.
    Yun KH; Mintz GS; Witzenbichler B; Inaba S; Shimizu T; Metzger DC; Rinaldi MJ; Mazzaferri EL; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Kirtane AJ; Stone GW; Maehara A
    JACC Cardiovasc Imaging; 2016 Jul; 9(7):849-854. PubMed ID: 26897675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.